AS602801 Treatment Suppresses Breast Cancer Metastasis to the Brain by Interfering with Gap-Junction Communication by Regulating Cx43 Expression

Investigators studied the molecular mechanism underlying the role of AS602801 in the treatment of brain metastasis in breast cancer. They utilized female athymic BALB/c nude mice and MDA-MB-231/BT-474BR cells to establish experimental models.